Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May 16;133(4):704-15.
doi: 10.1016/j.cell.2008.03.027.

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A Mani  1 , Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Cheng Zhang, Michail Shipitsin, Lauren L Campbell, Kornelia Polyak, Cathrin Brisken, Jing Yang, Robert A Weinberg
Affiliations

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A Mani et al. Cell. .

Abstract

The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The epithelial-mesenchymal transition (EMT) generates cells with properties of stem cells. (A) Phase-contrast images of HMLE cells expressing Snail, Twist or the control vector, as well as HMLE cells treated with recombinant TGF-β1 (2.5 ng/ml) for 12 days (bottom right). (B) Relative expression of the mRNAs encoding E-cadherin, N-cadherin, vimentin, and fibronectin in HMLE cells induced to undergo EMT by the methods outlined in panel A, as determined by Real-time RT-PCR. GAPDH mRNA was used to normalize the variability in template loading. The data are reported as mean +/− SEM). (C) FACS analysis of cell-surface markers, CD44 and CD24, in the cells described in panel A. (D) In vitro quantification of mammospheres formed by cells described in panel A. The data are reported as the number of mammospheres formed/1,000 seeded cells +/− SEM, (* - P < 0.05; *** - P<0.001 comparing to the control).
Figure 2
Figure 2
CD44high/CD24low cells exhibit many properties of stem cells. (A) CD44high/CD24low cells and CD44low/CD24high cells were separated by FACS. (B) Phase-contrast images of mammospheres seeded by CD44high/CD24low (top) and CD44low/CD24high (bottom) cells (C) Quantification of mammospheres formed by cells from the sorted CD44high/CD24low and CD44low/CD24high populations. The data are reported as mean +/− SEM (P<0.001). (D) Images of mammospheres immunostained with antibodies against basal cytokeratin 14 (K14, red) and luminal cytokeratin 8 (K8, green, top panel) or cytokeratin 18 (K18, green, bottom panel). In the merged images (right), the arrows indicate K8/K14 or K18/K14 double-positive cells (yellow). (E) Images of single-cell clones derived from CD44high/CD24low cells (left) or CD44low/CD24high cells (right) stained using antibodies against K14 (red) and K18 (green). The arrows indicate K14/K18 double-positive cells (yellow).
Figure 3
Figure 3
Stem-like/CD44high/CD24low cells isolated from HMLE cells exhibit attributes of cells that have undergone an EMT (A) Phase-contrast images (left) and immunofluorescence images of CD44high/CD24low and CD44low/CD24high cells stained using antibodies against E-cadherin, fibronectin or vimentin (right panels). (B) The expression levels of the mRNAs encoding E-cadherin, N-cadherin, vimentin, fibronectin, FOXC2, Slug, SIP1, Twist and Snail in CD44high/CD24low cells relative to CD44low/CD24high as determined by Real-time RT-PCR. GAPDH mRNA was used to normalize the variability in template loading. The data are reported as mean +/− SEM.
Figure 4
Figure 4
Primary mouse mammary stem cells, normal human breast stem-like cells, and neoplastic human breast stem-like cells express markers associated with EMT. (A) Primary mouse mammary epithelial cells were separated into CD49fhigh/CD24med and CD49fhigh/CD24med-depleted populations using FACS. (B) A representative image of a cleared mouse mammary fat pad reconstituted using 1000 of CD49fhigh/CD24med cells (top); the same number of CD49fhigh/CD24med-depleted cells failed to reconstitute the fat pad (bottom). (C) Phase-contrast images of CD49fhigh/CD24med and CD49fhigh/CD24med-depleted cells. (D) The expression levels of the mRNAs encoding E-cadherin, N-cadherin, vimentin, Slug and Twist in the CD49fhigh/CD24med relative to CD49fhigh/CD24med-depleted cells, as determined by Real-time RT-PCR. GAPDH mRNA was used to normalize variability in template loading. The data are reported as mean +/− SEM. (E) CD44high/CD24low cells (R4) and CD44low/CD24high cells (R3) were isolated from human reduction mammoplasty tissues using FACS. (F) The expression levels of the mRNAs encoding E-cadherin, N-cadherin, SIP-1 and FOXC2 in CD44high/CD24low cells (R4) relative to CD44low/CD24high cells (R3), as determined by Real-time RT-PCR. GAPDH mRNA was used to normalize the variability in template loading. The data are reported as mean +/− SEM. (G) Heat map depicting the expression levels of mRNAs encoding EMT markers in CD44high/CD24low cells compared to CD44low/CD24high cells, as determined by SAGE analysis. Red and green squares correspond to high and low mRNA levels, respectively.
Figure 5
Figure 5
EMT induces phenotypes associated with cancer stem cells. (A) Phase-contrast images of NeuNT-Snail-ER, NeuNT-Twist-ER and NeuNT-control vector cells treated with tamoxifen for a period of 10 days as well as images of untreated cells. (B) Western blot analysis of expression of HER2/neu, E-cadherin, fibronectin, and vimentin proteins in the cells shown in panel A. β-actin was used as a loading control. (C) Quantification of the mammospheres seeded by NeuNT-Snail-ER, NeuNT-Twist-ER or NeuNT-control vector cells treated or not treated with tamoxifen for 10 days. The data are reported as mean +/− SD. (D) Images of the colonies formed during soft agar culture of NeuNT-Snail-ER, NeuNT-Twist-ER and NeuNT-control vector cells after being treated with tamoxifen for 10 days. The soft agar assays were performed in the absence of tamoxifen. (E) Quantification of the soft agar colonies shown in panel D. The data are reported as mean +/− SD (** - P<0.01; *** - P<0.001 compared to the control).
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–3988. - PMC - PubMed
    1. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84–89. - PubMed
    1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine. 1997;3:730–737. - PubMed
    1. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005;5:744–749. - PubMed
    1. Briegel KJ. Embryonic transcription factors in human breast cancer. IUBMB life. 2006;58:123–132. - PubMed

Publication types